SCHEMBL24800989

SCHEMBL24800989

CN(C)c1ccc2cc(-c3nc4ccccc4s3)c(N)nc2c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ APP P05067 7/20 0.57
▸ MAPT P10636 7/20 0.54
▸ KDM4E B2RXH2 6/20 0.54
▸ RAB9A P51151 6/20 0.54
▸ MEN1 O00255 5/20 0.54
▸ KMT2A Q03164 5/20 0.54
▸ SMN1; SMN2 Q16637 4/20 0.54
▸ ALDH1A1 P00352 4/20 0.54
▸ NPC1 O15118 4/20 0.54
▸ GAA P10253 3/20 0.54
▸ TDP1 Q9NUW8 2/20 0.54
▸ L3MBTL1 Q9Y468 2/20 0.54
▸ POLB P06746 2/20 0.49
▸ HSD17B10 Q99714 2/20 0.48
▸ AHR P35869 1/20 0.48
▸ THRB P10828 1/20 0.47
▸ ALOX15 P16050 1/20 0.47
▸ CASP1 P29466 1/20 0.47
▸ SNCA P37840 1/20 0.47
▸ CASP7 P55210 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3211661 0.84 MAPT (0.63) APPMAPTKDM4ERAB9AMEN1
SCHEMBL5975744 0.79 MAPT (0.67) APPMAPTKDM4ERAB9AMEN1
SCHEMBL24800990 0.78 SREBF2 (0.44) APPMAPTKDM4ERAB9AMEN1
SCHEMBL24800992 0.76 APP (0.43) APPMAPTRAB9AMEN1KMT2A
SCHEMBL11224731 0.76 APP (0.76) APPMAPTKDM4ERAB9AMEN1
SCHEMBL31022177 0.76 PIK3CD (0.69) APPMAPTKDM4ERAB9AMEN1
SCHEMBL2381840 0.76 PIK3CD (0.69) APPMAPTKDM4ERAB9AMEN1
SCHEMBL4949115 0.75 APP (0.58) APPMAPTKDM4ERAB9AMEN1
SCHEMBL61917 0.73 APP (1.00) APPMAPTKDM4ERAB9AMEN1
SCHEMBL16739391 0.73 TERT (0.49) APPMAPTRAB9AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022271676-A1 INDOLE-SUBSTITUTED QUINOLINES AND THEIR COMBINATION WITH PLK1 INHIBITORS FOR THE TREATMENT OF CANCER UNIVERSITY OF KENTUCKY RESEARCH FOUNDATION (US) 2022-12-29 — — WO disclosed
Send feedback